Buy Fresenius
It’s no surprise to find that acquisitions have been long been driving this company’s ambitious growth strategy. Last year, the company spent $367M. (Editor’s note: And, they’ve already well exceeded that for this year!)
Read the full article » | Posted 08-17-2017
Related Articles
- Nephrologist Dr. Roberto Collazo Shares New Treatments for Kidney Disease and ESKD Posted 12-11-2024
- Ellen Lukens from CMMI Presents on the Kidney Care Choices Model Posted 12-11-2024
- 2025 NKF Survey on Kidney Health Priorities Finds Home Dialysis is a Patient Priority Posted 12-11-2024
- FDA Correction on Baxter MiniCap Extended Life PD Transfer Set Posted 12-11-2024